Korean Drug Co., Ltd.

014570.KQ·KOSDAQ·Healthcare
Compare
3,040.00−50.00 (−1.62%)today
As of Oct 22, 2:23 PM KST · May be delayed up to 20 min · KRW

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close3,090.00
Open3,155.00
Day range3,010.003,155.00
52-week range2,865.004,550.00
Off day high−3.65%
Off 52-week high−33.19%
Volume4.10K
Avg. volume (3M)5.95K
Market cap32.91B
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield5.83% (180.00)
Beta (5Y)0.23
Shares outstanding10.83M
Short interest—
Earnings date—
Analyst target—
Profit margin2.27%

Against its peers

Compare in full ›
014570.KQ 002422.SZ GSK CUP.F 4552.T 1093.HK
Market cap 32.91B 66.72B 100.22B 59.83B 65.28B 95.52B
P/E (TTM) — 36.5 15.8 22.9 79.9 11.5
Forward P/E — 28.0 10.2 0.2 14.6 12.6
Price/book — 2.7 4.2 5.2 1.5 2.2
Dividend yield 5.83% 1.38% 3.59% 2.08% 3.76% 4.14%
1-year change −27.38% +23.82% +14.39% −12.21% −13.07% +2.84%
Today −1.62% −2.67% −1.20% +1.71% +0.56% −3.74%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.

AJP·Negative

Incheon stabbing puts Koreas drug-violence link under scrutiny

Aju Press Incheon stabbing puts Korea's drug-violence link under scrutiny Food and Drug Administration Faces Criticism Over Delayed Response to Weight Loss Drug Side Effects Confidential Documents from South Korea's Food and Drug…

Seoul Economic Daily·Negative

Korea Drug Agency Rules Out Bridging Trials for Abortion Pill

Seoul Economic Daily South Korea's Ministry of Food and Drug Safety reaffirmed that it will not conduct separate bridging trials on Korean subjects before introducing mifepristone, the abortion pill widely known as Mifegyne Addressing…

CHOSUNBIZ·Negative

Genencell lobbying row stalls South Korea drug safety audit

Genencell lobbying row halts South Korea drug safety hearing - CHOSUNBIZ Chosunbiz Genencell lobbying row stalls South Korea drug safety audit Audit briefly collapses amid partisan clash over Genencell witness demands The National Assembly…

Seoul Economic Daily·Negative

Seven in 10 Who Left Korea's Drug Rehab Agency Quit Within a Year

64% of New Hires Resigned Within Eight Months 71% of Last Year's Departures Had Served Less Than a Year New employees are leaving in rapid succession at the public agency responsible for counseling and rehabilitating drug addicts. Of 22…

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.